We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Interdisciplinary Research in Medical Sciences Specialty

2022 Volume 2 Issue 2

Mortality and Disability Attributable to Adverse Medical Treatment Effects in India: Insights from the 2019 Global Burden of Disease Study


, ,
  1. Department of Clinical Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract

Patient harm due to unsafe medical care can result in hospitalization, long-term disability, or death. In India, where access to tertiary healthcare varies widely across its large and heterogeneous population, there is limited research evaluating the burden of adverse medical events. This study assessed the impact of adverse effects of medical treatment (AEMT) in India between 2010 and 2019 using data from the Global Burden of Disease (GBD) 2019 study. We estimated national-level deaths and disability-adjusted life years (DALYs) associated with AEMT, further analyzing differences across age groups and genders. Findings indicate that AEMT accounts for less than 0.01% of all-cause deaths and DALYs. From 2010 to 2019, the death rate showed a marginal decline from 2.34 (1.75–2.66) to 2.33 (1.73–2.86) per 100,000 population. The 50–74-year age group and females experienced the highest burden in terms of both deaths and DALYs. Although AEMT contributes minimally to overall mortality, its potential underreporting and effects on public confidence in healthcare merit further research.


How to cite this article
Vancouver
Larsen H, Hansen M, Pedersen S. Mortality and Disability Attributable to Adverse Medical Treatment Effects in India: Insights from the 2019 Global Burden of Disease Study. Interdiscip Res Med Sci Spec. 2022;2(2):101-10. https://doi.org/10.51847/MlwJ8Hnq8L
APA
Larsen, H., Hansen, M., & Pedersen, S. (2022). Mortality and Disability Attributable to Adverse Medical Treatment Effects in India: Insights from the 2019 Global Burden of Disease Study. Interdisciplinary Research in Medical Sciences Specialty, 2(2), 101-110. https://doi.org/10.51847/MlwJ8Hnq8L

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.